https://www.selleckchem.com/products/pq912.html
In the developed world, 5-years survival of childhood acute myeloid leukaemia (AML) has improved to 70%. However, the survival rates in the developing world are below 40%. The main contributing factors to these reduced survival rates are a late presentation, malnutrition and high treatment-related mortality. To document the factors affecting treatment outcome of childhood AML at a tertiary care facility of Pakistan. All newly registered cases of AML under 18 years of age from January 1, 2012 onwards who completed their treatment before No
Mi piace
Commento
Condividi
